Congress Abstracts 2003
Ambulatory and Community Services
5
DESIGNING OUTPATIENT FLOW: SAILING THROUGH THE STORM
6
EFFECTIVE STRATEGIES FOR DECREASING UNSCHEDULED WALK-IN INFUSION APPOINTMENTS
7
LINICAL INSIGHTS SHARED BY NURSE CANCER SURVIVORS
8
COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN THE PROSTATE CANCER POPULATION: THE ROLE OF THE AMBULATORY NURSE
59
EMPLOYEE MAMMOGRAPHY INREACH PROGRAM AS A MODEL FOR EFFECTIVE BREAST CANCER SCREENING
60
WALKER COUNTY, AL, CANCER SCREENING PROJECT
61
MEDICATION ERROR PREVENTION IN THE OFFICE SETTING
62
A RECOGNIZED NEED: BLADDER CANCER SUPPORT GROUP AND THE ROLE OF THE AMBULATORY NURSE
63
AN EVALUATION OF A STRUCTURED CHEMOTHERAPY TEACHING PROGRAM IN AN AMBULATORY SETTING
64
USE OF THE TELEPHONE FOR DELIVERY OF NURSING INTERVENTIONS
65
HOME HEALTH VERSUS TELENURSING OUTPATIENT MANAGEMENT OF ONCOLOGY PATIENTS WITH NEW OSTOMIES
66
THE ADMINISTRATIVE CHALLENGE IN THE DEVELOPMENT OF A POINT-OF-SERVICE CLINIC FOR POST BLOOD AND MARROW TRANSPLANTATION PATIENTS
67
ADVANCED CANCERS OF THE ORAL CAVITY: THE ROLE OF THE AMBULATORY CARE NURSE
68
IMPROVING THE USE OF ANTIEMETICS FOR PROPHYLAXIS OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN AN OUTPATIENT CANCER CENTER
69
A SYSTEM FOR THE SAFE ADMINISTRATION OF ORAL CHEMOTHERAPEUTIC AGENTS IN THE HOME SETTING
70
OUTPATIENT DOCUMENTATION FORMS FOR CHEMOTHERAPY AND RADIATION: COMPLYING WITH ONCOLOGY NURSING SOCIETY GUIDELINES
72
A COMMUNITY-FOCUSED MODEL FOR INTEGRATING A COMMUNITY-BASED GENETIC PROGRAM WITH A COMMUNITY CLINICAL ONCOLOGY PROGRAM: A NURSING INITIATIVE FOR PROGRAM DEVELOPMENT AND CANCER INTERVENTION
73
THE IMPACT OF MEDICAL VISITS ON PATIENTS WITH CANCER
74
A UROLOGIC CANCER SECOND OPINION SERVICE: HELPING PATIENTS MAKE INFORMED TREATMENT DECISIONS
76
EFFICIENT SYSTEM TO SCHEDULE CHEMOTHERAPY AND SUPPORT THERAPIES FOR ONCOLOGY NURSES
Breast Cancer Management
55
LYMPHEDEMA FOLLOWING BREAST CANCER TREATMENT, INCLUDING SENTINEL LYMPH NODE BIOPSY
98
"WHAT SHOULD I TELL MY CHILDREN?": AN ONCOLOGY NURSING PERSPECTIVE
99
RELIEF FROM HOT FLASHES: DEFINING DISTRESS AND SATISFACTION
100
CHEMOTHERAPY-INDUCED MENOPAUSAL SYMPTOMS IN WOMEN 21-45 YEARS OF AGE
101
OPENING THE WINDOW ON HOT FLASHES
102
PEGFILGRASTIM WAS OBSERVED TO BE AS SAFE AND EFFECTIVE AS FILGRASTIM IN ELDERLY PATIENTS WITH BREAST CANCER
103
PROMOTING BREAST HEALTH AMONG YOUNG WOMEN IN COLLEGE THROUGH BREASTIVAL EVENTS
104
"NO, IT'S NOT MASTITIS": DIAGNOSIS OF AND INNOVATIVE COMBINATION TREATMENT FOR INFLAMMATORY BREAST CANCER
105
EXPANDING THE COMFORT OF MASTECTOMY PATIENTS WITH THE PAPILLA GOWN
106
FATIGUE, DEPRESSION, AND BIOMARKERS IN WOMEN WITH BREAST CANCER: A PILOT STUDY
108
CONTEMPORARY MEASUREMENT OF SYMPTOM DISTRESS IN WOMEN WITH BREAST CANCER
109
WEIGHT AND BODY COMPOSITION CHANGES IN PREMENOPAUSAL WOMEN RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER
110
INFORMATION NEEDS OF WOMEN WITH BREAST CANCER IN RECOVERY
111
VIRTUAL REALITY INTERVENTION FOR OLDER WOMEN WITH BREAST CANCER
112
FACTORS RELATED TO DELAYED HEALTH-SEEKING BEHAVIOR IN PATIENTS WITH BREAST CANCER
113
EVIDENCE-BASED PRACTICE: PSYCHOSOCIAL CARE FOR WOMEN NEWLY DIAGNOSED WITH BREAST CANCER
114
A PILOT STUDY TO EXPLORE THE RESOURCES AND THE SELF-CARE ACTIVITIES OF WOMEN WITH SIDE EFFECTS FROM CONVENTIONAL BREAST CANCER THERAPY
115
USING A SYMTOM DISTRESS TOOL IN AN OUTPATIENT BREAST CENTER
116
SISTERS FOR BREAST HEALTH: IMPROVING THE HEALTH OF THE COMMUNITY
Cnacer Prevention
28
PERCEIVED CANCER WORRY IN WOMEN WITH HEREDITARY RISK FACTORS FOR BREAST CANCER
29
CANCER FAMILY HISTORY: HOW TO DRAW A PEDIGREE
31
DEVELOPING NICARAGUAN NURSES AS LEADERS IN CANCER PREVENTION AND CONTROL: PREPARATION FOR A NURSE-MANAGED, COMMUNITY-BASED BREAST AND CERVICAL CANCER PREVENTION AND CONTROL PROGRAM
Clinical Therapies and Associated Care
16
THE TREATMENT OF ADVANCED PROSTATE CANCER WITH KETOCONAZOLE
19
MANAGING PATIENT POST HEPATIC ARTERIAL EMBOLIZATION: THE INPATIENT NURSE'S ROLE
40
ENGRAFTMENT SYNDROME POST NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: NURSING'S ROLE IN EARLY DETECTION AND TREATMENT
48
THE NURSING ROLE IN THE MANAGEMENT OF STEREOTACTIC RADIOSURGERY FOR BRAIN TUMORS
49
A NOVEL APPROACH TO TREATING PATIENTS AFTER RESECTION OF MALIGNANT BRAIN TUMORS: DEVELOPMENT OF A NURSING CARE PLAN
51
A PHASE I/II STUDY TO EVALUATE THE OPTIMUM DOSE OF PEGYLATED-INTERFERON IN PATIENTS WITH PLATINUM-RESISTANT OVARIAN, PERITONEAL, OR FALLOPIAN TUBE CANCER: A NEW TREATMENT APPROACH FOR PATIENTS WITH RECURRENT DISEASE
52
WHAT'S OLD IS NEW AGAIN: PATIENTS RECEIVING HEPATIC INTRA-ARTERIAL CHEMOTHERAPY
53
TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA WITH HIGH-DOSE METHOTREXATE: NURSING'S UNIQUE CONTRIBUTION
54
ARSENIC TRIOXIDE: NURSING CONSIDERATIONS FOR SAFE ADMINISTRATION
71
CARING FOR OUTPATIENTS RECEIVING RADIOLABELED PHARMACEUTICAL AGENTS: GUIDELINES AND EDUCATIONAL TOOLS
75
MANAGING VANCOMYCIN-RESISTANT ENTEROCOCCI IN IMMUNO-SUPPRESSED BLOOD AND MARROW STEM CELL TRANSPLANTATION PATIENTS IN THE OUTPATIENT SETTING: ARE WE DOING ENOUGH?
91
GLEEVEC™ TREATMENT FOR CHRONIC MYELOID LEUKEMIA: THE NURSING MANAGEMENT CHALLENGE FROM CLINICAL TRIALS TO THE PRESENT
92
HORMONAL MANIPULATIONS FOR PROSTATE CANCER: THE AMBULATORY NURSE PRACTITIONER'S ROLE
93
THE ROLE OF THE ONCOLOGY NURSE IN IMPLEMENTING NEW TARGETED THERAPIES
94
NURSING PRIMER ON CANCER VACCINES: WHAT YOU NEED TO KNOW TO EDUCATE YOUR PATIENTS
95
GELCLAIR™: A NEW, PROMISING, COST-EFFECTIVE, ORAL AGENT FOR THE REDUCTION OF MUCOSITIS SEQUELAE
96
PS 341: A NEW DRUG FOR THE TREATMENT OF RENAL CELL CARCINOMA: THE AMBULATORY NURSE'S ROLE
97
A PHASE I/II STUDY OF XYOTAX™ (CT-2103), A TUMOR-TARGETED TAXANE, IN PATIENTS WITH RECURRENT OVARIAN CANCER
156
NAIL CHANGES FOLLOWING INTRAVENOUS TAXOTERE®
159
NURSING ROLE IN THE DELIVERY OF IBRITUMOMAB TIUXETAN (ZEVALIN™) RADIOIMMUNOTHERAPY: WHAT TO EXPECT
161
THALIDOMIDE: TOXICITY PROFILE AND NURSING IMPLICATIONS
183
COULD THIS BE LEPTOMENINGEAL METASTASIS?
186
POSITRON EMISSION TOMOGRAPHY: A NEW TREND IN ONCOLOGIC IMAGING
190
USE OF VACUUM-ASSISTED WOUND CLOSURE SYSTEM IN AN ONCOLOGY SETTING
Complementary Therapies
57
OUTCOMES OF COMPLEMENTARY THERAPY USE BY CHEMOTHERAPY PATIENTS
123
OPTIMIZED USE OF PHARMACOLOGIC AND COMPLEMENTARY THERAPIES TO DECREASE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
124
EDUCATION FOR ONCOLOGY NURSING: APPLYING COMPLEMENTARY AND ALTERNATIVE MEDINCE IN THE PRACTICE SETTING
125
AROMATHERAPY: GUIDELINES FOR SAFE INCORPORTATION INTO NURSING PRACTICE
126
SUPPORTING THE SPIRITUAL CONNECTION: CREATION AND DEVELOPMENT OF A SPIRITUALITY QUEST GROUP FOR CANCER SURVIVORS
127
LAUNCHING A COMPLEMENTARY THERAPY PROGRAM IN ONCOLOGY: A NURSING INITIATIVE IN HOLISTIC CARE
128
CREATING AN ENVIRONMENT FOR CARING THROUGH STORYTELLING
129
CANCER FITNESS: OUTCOME MEASURES AND FEATURES OF A THREE-TIERED PROGRAM
130
COMPLEMENTARY AND ALTERNATIVE MEDICINE IN THE 21ST CENTURY IN THE UNITED STATES
131
ROCKY MOUNTAIN TEAM SURVIVOR: A MODEL FOR A FITNESS AND ACTIVITY SUPPORT PROGRAM DESIGNED TO ENHANCE AND IMPROVE OVERALL QUALITY OF LIFE FOR WOMEN CANCER SURVIVORS
132
DEVELOPING AND IMPLEMENTING A FAMILY-CENTERED CARE PROGRAM IN AN ACUTE CARE ONCOLOGY UNIT
133
MEETING PATIENT NEEDS: INTEGRATING A HEALING ARTS PROGRAM TO CANCER CARE AND INTRODUCING THEM IN A UNIQUE AND MEANINGFUL WAY
End-of-Life and Palliative Care
20
END-OF-LIFE EDUCATION FOR CONTINUING EDUCATION PROVIDERS
21
TOTAL SYMPTOM SCORES IMPACT HOSPICE PATIENTS' FUNCTIONAL STATUS AND QUALITY OF LIFE
22
GRIEF AND LOSS FOR PROFESSIONALS: PROVIDING A SHELTERING FORUM FOR EXPRESSION, FEEDBACK, AND VALIDATION THROUGH "STAFF GRIEF AND LOSS ROUNDS."
23
TESTING OUTCOMES OF PALLIATIVE CARE AND SYMPTOM MANAGEMENT TRAINING FOR PARAPROFESSIONALS (NURSING ASSISTANTS AND HOME HEALTHCARE AIDES) IN THE NURSING HOME AND REHABILITATION SETTING
162
EVALUATION OF ADVANCED PRACTICE NURSING MANAGEMENT AND INTERVENTION IN A COLLABORATIVE ONCOLOGY AND PALLIATIVE CARE CLINICAL TRIAL FOR A LUNG CANCER PATIENT POPULATION IN A COMPREHENSIVE CANCER CENTER AT AN ACADEMIC INSTITUTION
163
NURSING INTERVENTION PROTOCOL FOR PATIENTS WITH TERMINAL CANCER IN KOREA
164
IMPROVING ONCOLOGY NURSES' ATTITUDES AND KNOWLEDGE OF PALLIATIVE CARE
165
UNDERGRADUATE NURSING EDUCATION IN END-OF-LIFE CARE: PARTICIPATION IN A PALLIATIVE CARE COMPANION PROGRAM
166
HOPES, CONCERNS, AND EXPECTATIONS OF POOR PEOPLE LIVING WITH CANCER ABOUT CARE AT THE END OF LIFE
167
ETHICS AT THE END OF LIFE: AUTONOMY AND CONTROL
168
PROVIDING PALLIATIVE CARE TO THE UNDERSERVED: A CASE STUDY
Evidence-Based Practice
35
EVIDENCE-BASED PRACTICE: A METHOD OF IMPROVING NURSING PRACTICE
Fatigue Management
58
SLEEP, FATIGUE, AND DEPRESSIVE SYMPTOMS IN BREAST CANCER SURVIVORS AND MATCHED HEALTHY WOMEN EXPERIENCING HOT FLASHES
118
PATIENT-REPORTED DEPRESSION AND ANXIETY IN PATIENTS WITH CANCER IMPROVES FOLLOWING REDUCTION IN ANEMIA-RELATED FATIGUE WITH DARBEPOETIN ALFA THERAPY
134
EFFECTS OF EXERCISE ON DAILY FATIGUE IN WOMEN WITH BREAST CANCER UNDERGOING CHEMOTHERAPY
135
QUALITY OF LIFE AND FATIGUE IN LUNG CANCER PATIENTS: DOES A SEATED EXERCISE PROGRAM MAKE A DIFFERENCE?
136
SYMPTOM CLUSTERS PREDICT FATIGUE SEVERITY IN ONCOLOGY OUTPATIENTS
137
INFLUENCE OF INTENSIVE CANCER PAIN MANAGEMENT IN THE DEVELOPMENT OF FATIGUE, HALLUCINATION, AND SEDATION
138
WHO BENEFITS FROM ENERGY CONSERVATION FOR CANCER-RELATED FATIGUE?
139
FACTORS ASSOCIATED WITH FATIGUE IN WOMEN BEFORE AND AFTER SURGERY FOR BREAST CANCER
140
FACTORS INFLUENCING FATIGUE DURING AND AFTER CHEMOTHERAPY: RESULTS OF A FEASIBILITY SLEEP INTERVENTION STUDY
141
EVALUATING THE CLINICAL IMPORTANCE OF A FATIGUE ASSESSMENT TOOL: A PILOT STUDY
142
WOMEN RECEIVING ADJUVANT CHEMOTHERAPY FOR BREAST CANCER: IMPACT ON QUALITY OF LIFE AND FATIGUE
Neutropenia
39
THE EXPERIENCE OF CHEMOTHERAPY-INDUCED NEUTROPENIA: QUALITY-OF-LIFE INTERVIEWS WITH ADULT CANCER PATIENTS
42
THE DEVELOPMENT OF A COMMUNITY ONCOLOGY COST MODEL FOR CHEMOTHERAPY-INDUCED NEUTROPENIA
46
EVIDENCE-BASED PRACTICE GUIDELINES FOR PROACTIVE MANAGEMENT OF NEUTROPENIA
117
RATIONALE FOR THE DEVELOPMENT OF THE FACT-N: A NEUTROPENIA-SPECIFIC QUALITY-OF-LIFE TOOL
119
EFFECTS OF THE NEUTROPENIC DIET IN THE OUTPATIENT SETTING
120
TARGETED COLONY-STIMULATING FACTOR USE IN PATIENTS AT RISK FOR NEUTROPENIC COMPLICATIONS FROM BREAST CANCER ADJUVANT CHEMOTHERAPY: CLINICAL IMPACT OF A PREDICTIVE RISK MODEL
121
PEGFILGRASTIM (NEULASTA™) SUPPORTS DOSE-DENSE CHOP-R GIVEN EVERY 14 DAYS TO PATIENTS WITH NON-HODGKIN LYMPHOMA
122
NEUTROPENIC PRECAUTIONS: A JOURNEY TO THE DEVELOPMENT OF EVIDENCE-BASED STANDARDS
Outcomes
43
A PROSPECTIVE EVALUATION OF PALLIATIVE OUTCOMES OF SURGERY FOR ADVANCED MALIGNANCIES
44
RESPIRATORY SYMPTOMS AND PULMONARY STATUS OF SURVIVORS OF NON-SMALL CELL LUNG CANCER
45
A PROSPECTIVE STUDY OF PATIENT SENSATIONS AFTER BREAST CANCER SURGERY: A TWO-YEAR FOLLOW-UP
77
NEUTROPENIA IN ONCOLOGY PATIENTS: STANDARDIZING AN EDUCATION-AL APPROACH AND MEASURING OUTCOMES
Pain Management
47
IMPROVING PAIN MANAGEMENT FOR THE POSTOPERATIVE THORACIC SURGERY ONCOLOGY PATIENT UTILIZING EPIDURAL INFUSIONS
143
THE INFLUENCE OF CAREGIVER AGE AND GENDER, AND PATIENT CLINICAL FACTORS ON FAMILY CAREGIVERS' PERCEPTIONS OF AND INVOLVEMENT IN CANCER PAIN MANAGEMENT
145
A PILOT STUDY COMPARING PAIN INTENSITY, INFORMATION SEEKING, AND ADJUSTMENT TO PROSTATE CANCER AND METASTASIS IN FIRST-GENERATION JAPANESE AMERICAN MEN AND THIRD-GENERATION EUROPEAN AMERICAN MEN
146
HISPANIC PERSPECTIVES ABOUT BELIEFS AND REMEDIES FOR ACUTE PAIN
147
OPIOID PRESCRIPTION FOR CANCER PAIN MANAGEMENT
148
CANCER-RELATED PAIN IN THE OUTPATIENT CLINIC
149
WHEN IS RELIEF FROM CANCER PAIN POOR, FAIR, OR GOOD?
150
AN INSTITUTIONAL EXPERIENCE WITH THE IMPLEMENTATION OF JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS PAIN STANDARDS
151
PAIN IN ADULT RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN KOREA
152
GAINS ON PAIN
Patient Care
17
ADVANCING ONCOLOGY NURSING PRACTICE: MONTHLY COLLABORATIVE CASE STUDY PRESENTATIONS
18
MULTIDISCIPLINARY MANAGEMENT OF CANCER-RELATED MALNUTRITION IN AN INPATIENT GASTROINTESTINAL/HEPATOBILIARY UNIT
41
HEALTH PROMOTION AND BACK TO BASICS: INFLUENZA VACCINATION IN AN ADULT ONCOLOGY POPULATION
56
NURSING BEHAVIORAL INTERVENTION TRIAL RESULTS IN FEWER HOSPITALIZATIONS AMONG CANCER PATIENTS UNDERGOING CHEMOTHERAPY
Patient Education
50
PROVIDING INFORMATION FOR PATIENT RECOVERY: CREATION OF AN EDUCATION BOOKLET FOR BLADDER CANCER PATIENTS FOLLOWING CYSTECTOMY WITH NEOBLADDER RECONSTRUCTION
78
"BUTT BUSTERS: KIDS AGAINST SMOKING": A PROGRAM TO EDUCATE ELEMENTARY STUDENTS ABOUT THE DANGERS OF SMOKING
79
A BREATH OF FRESH AIR: ONCOLOGY NURSES INCREASING THE COMMUNITY'S AWARENESS ABOUT LUNG CANCER
80
DEVELOPMENT AND IMPLEMENTATION OF PATIENT AND FAMILY EDUCATION COORDINATOR ROLE FOR HOSPITALIZED ONCOLOGY PATIENTS
81
THE HEPATIC ARTERIAL INFUSION THERAPY: THE INPATIENT NURSE'S ROLE IN PREVENTING COMPLICATIONS AND MAINTAINING PATIENT SAFETY THROUGH PATIENT EDUCATION
82
A PATIENT EDUCATION VIDEO TO ENHANCE LEARNING OF ESSENTIAL INFORMATION IN THE IMMEDIATE POSTOPERATIVE PERIOD FOLLOWING SURGERY FOR BREAST CANCER
83
NURSES AND PATIENTS: PARTNERS IN DEFINING EDUCATIONAL NEEDS
84
OUTCOME EVALUATION OF A PATIENT EDUCATION NOTEBOOK FOR WOMEN WITH GYNECOLOGIC MALIGNANCY
85
A PATIENT GUIDE TO CARE: COLLABORATION BY DEPARTMENT OF PATIENT PROVIDERS TO IMPROVE PATIENT EDUCATION
86
SERVING MINORITIES: CREATING A COLLABORATIVE APPROACH TO MEET THE EDUCATIONAL NEEDS OF MULTICULTURAL INDIGENT GYNECOLOGIC CANCER PATIENTS
87
PATIENT EDUCATION MATERIAL FOR CUTTING-EDGE CANCER TREATMENTS: NURSES IN INDUSTRY AND AT THE BEDSIDE COLLABORATING ON A CANCER VACCINE EDUCATIONAL TOOL
88
GETTING MORE INFORMATION ABOUT THE PROBLEM: AN IMPORTANT COMPONENT FOR IMPROVEMENT OF PATIENT SATISFACTION
89
AN INNOVATIVE APPROACH TO UTILIZING CANCER SURVIVORS IN TELEPHONE PEER SUPPORT PROGRAMS FOR BREAST CANCER AND PROSTATE CANCER PATIENTS
Professional Development
12
SAFEGUARDING AN ENDANGERED SPECIES: SUSTAINING THE HEART, MIND, AND SPIRIT OF THE ONCOLOGY CAREGIVER
13
BEYOND ORIENTATION: SUPPORTING THE NEW AND EXPERIENCED ONCOLOGY NURSE
14
DEVELOPING AND IMPLEMENTING A CONSULTATIVE SERVICE FOR NURSES PURSUING OCN® CERTIFICATION
15
MONITORING, MEASURING, AND MANAGING CANCER NURSING RESOURCES: RESULTS OF ONE INSTITUTION'S "REPORT CARD" EFFORTS
26
HANDS-ON LEARNING: EDUCATING NEW ONCOLOGY NURSES IN A SKILLS LAB ENVIRONMENT
27
THE CHEMO OLYMPICS: A FUN APPROACH TO SAFETY IN CHEMOTHERAPY PRACTICE.
32
PERFORMANCE IMPROVEMENT: STRATEGIES FOR SUCCESS
178
CULTURAL COMPETENCE: ARE YOU PREPARED FOR THE CHALLENGE?
179
ONCOLOGY NURSING ASSISTANT DEVELOPMENT PROGRAM: A PARTNERSHIP APPROACH TO ADDRESS HEALTHCARE CHALLENGES
180
SEXUALITY AND CANCER: HOW ONCOLOGY NURSES CAN ADDRESS IT BETTER
181
A MODEL FOR PROFESSIONAL DEVELOPMENT
182
PUBLISH OR PERISH: NURSES WRITING FOR THE PROFESSION
184
LEVEL OF KNOWLEDGE AND COMPLIANCE WITH WORK PRACTICE GUIDELINES FOR PERSONNEL DEALING WITH CYTOTOXIC DRUGS: COMPARISON BY CLINICAL NURSE'S JOB CAREER AND WORK SITES
187
DESPERATELY SEEKING SUSAN OR ANY OTHER ONCOLOGY NURSE TO BECOME OCN® CERTIFIED (A.K.A. GOT OCN®?)
188
SYNTHESIS OF RESEARCH EVIDENCE: COLLABORATION AMONG PRACTITIONERS, EDUCATORS, AND RESEARCHERS
189
A COMPETENCY-BASED ORIENTATION FOR ADVANCED PRACTICE NURSES
192
IMPLEMENTATION OF A POCKET REFERENCE TOOL FOR REGISTERED NURSES INEXPERIENCED IN THE CARE OF COMPLEX ONCOLOGY PATIENTS IN THE HOSPITAL SETTING
193
PREPARING NURSES IN BIOMEDICAL RESEARCH
194
THE MASSACHUSETTS GENERAL HOSPITAL CANCER NURSING FELLOWSHIP: INTRODUCING CANCER CARE TO THE NEXT GENERATION OF NURSES
195
ARE YOU READY TO PRACTICE?
196
"RESEARCH TO PRACTICE": A PRACTICAL PROGRAM TO ENHANCE THE USE OF EVIDENCE-BASED PRACTICE AT THE UNIT LEVEL
197
THE DEVELOPMENT OF SKILL SETS, COMPETENCIES, AND EDUCATIONAL PROGRAMMING TO PROMOTE GOOD CLINICAL PRACTICE FOR RESEARCH NURSES IN CLINICAL TRIALS
198
INTEGRATION OF THE PEDIATRIC PATIENT POPULATION INTO A PREDOMINANTLY ADULT BLOOD AND MARROW TRANSPLANT PROGRAM
Program Development
1
THE REVISED I CAN COPE-A MODEL OF COLLABORATION
2
DEVELOPING A COMPREHENSIVE ART THERAPY PROGRAM
3
A MULTIDISCIPLINARY APPROACH TO CREATING A BEREAVEMENT PROGRAM IN A TERTIARY HOSPITAL SETTING
4
DELEtCC: DISSEMINATING END-OF-LIFE EDUCATION TO CANCER CENTERS
Quality Improvement and the Joint Commission on Accreditation of Healthcare Organizations
24
IMPROVING CHEMOTHERAPY SAFETY IN A MULTISPECIALTY TERTIARY REFERRAL CENTER
25
DON'T WAIT FOR SOMETHING BAD TO HAPPEN TO CHANGE PRACTICE: AVOIDANCE OF SENTINEL EVENTS BY LEARNING FROM NEAR MISSES
225
IMPACT OF AN INPATIENT ONCOLOGY NURSE PRACTITIONER ON SELECTED OUTCOMES IN AN ACADEMIC MEDICAL CENTER
226
RE-EVALUATING A PATIENT SAFETY PROGRAM IN AN ONCOLOGY NURSING SETTING
227
THE BUCK STOPS HERE: ONLINE ACTUAL AND NEAR-MISS MEDICATION ERROR REPORTING
228
ADDRESSING THE "MISSING PIECES" IN ACUTE MYELOID LEUKEMIA INDUCTION THERAPY
229
PERFORMANCE IMPROVEMENT: EVALUATING AN EDUCATIONAL TOOL TO ENHANCE PATIENT OUTCOMES
230
COMMITMENT TO QUALITY PATIENT CARE
231
FACT ACCREDITATION: A MULTIDISCIPLINARY MODEL FOR PREPARATION FOR THE ACCREDITATION PROCESS
232
GETTING TO THE ROOT OF CHEMOTHERAPY ERRORS: USING A ROOT CAUSE ANALYSIS APPROACH TO CHEMOTHERAPEUTIC MEDICATION ORDERING
233
THE COMPREHENSIVE CANCER CENTER CONSORTIUM FOR QUALITY IMPROVEMENT'S PATIENT SATISFACTION INITIATIVE
234
INCORPORATING KEY VALUES AND JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS FUNCTIONS INTO ONCOLOGY QUALITY IMPROVEMENT
235
EVALUATION OF THE ROLE OF QUALITY IMPROVEMENT IN PROFESSIONAL DEVELOPMENT
236
COLLABORATIVE APPROACH TO CASE MANAGEMENT
237
THE DEVELOPMENT OF A VIRTUAL WORK GROUP OF THE ONCOLOGY NURSING SCOIETY CLINICAL TRIALS NURSES SPECIAL INTEREST GROUP: KEYS TO PRODUCTIVITY
238
USING TECHNOLOGY TO IMPROVE CLINICAL PRACTICE
239
COLORADO CANCER RESOURCE GUIDE ONLINE PROJECT
240
USING PLAIN LANGUAGE AND INFORMATION MAPPING TO COMMUNICATE HEALTH INFORMATION ONLINE
241
BAR CODE READER INTRODUCED AT GEORGETOWN UNIVERSITY HOSPITAL
242
DEFINING THE CHARACTERISTICS OF YOUR PATIENT CARE AREA: USING TECHNOLOGY TO CREATE A UNIT PROFILE AND TO SIMPLIFY DATA COLLECTION AND ANALYSIS
243
DEVELOPMENT OF A COMPUTERIZED ONCOLOGY NURSING DOCUMENTA-TION PATHWAY: COLLABORATION YIELDS RESULTS
Research to Improve Patient Care
9
TRANSCENDING BREAST CANCER
10
ENHANCING ADAPTATION FOLLOWING RADIATION TREATMENT: CONCRETE INFORMATION VERSUS EMOTIONAL EXPRESSION
11
IMPROVING CANCER PAIN MANAGEMENT FOR HOMECARE NURSES
36
MEASURING NAUSEA, VOMITING, AND RETCHING: THE MODIFIED RHODES INDEX OF NAUSEA AND VOMITING SHORT VERSION FOR RESEARCH AND CLINICAL USE
37
SYMPTOM TRAJECTORY FOLLOWING 12 WEEKS OF BIOTHERAPY
38
EVALUATING THE RELATIONSHIP BETWEEN CANCER PAIN INTENSITY, SATISFACTION WITH PAIN RELIEF, AND ATTITUDINAL BARRIERS TO PAIN MANAGEMENT: ANOTHER LOOK
199
IDENTIFYING SYMPTOMS THAT CLUSTER IN WOMEN WITH OVARIAN CANCER
200
PERCEPTIONS OF THE CAREGIVING EXPERIENCE AND QUALITY OF LIFE OF MEXICAN/MEXICAN AMERICAN CAREGIVERS PROVIDING CARE TO ADULTS WITH ADVANCED CANCER
201
DEPRESSIVE SYMPTOMS IN A SAMPLE OF WOMEN PARTICIPATING IN AN OVARIAN CANCER EARLY DETECTION PROGRAM
202
CAUSAL ATTRIBUTIONS OF WOMEN WITH OVARIAN CANCER
203
FACTORS THAT INFLUENCE QUALITY OF LIFE, HOPE, AND SYMPTOM DISTRESS IN BREAST AND COLORECTAL CANCER PATIENTS
204
WHAT IT TAKES TO MAKE COOPERATIVE CARE WORK
205
INCREASING TESTICULAR SELF-EXAMINATION IN ACTIVE DUTY SOLDIERS: AN INTERVENTION STUDY
206
PSYCHOMETRIC PROPERTIES OF THE ITALIAN VERSION OF THE BRIEF FATIGUE INVENTORY
207
THE DERMATOLOGY LIFE QUALITY INDEX: A USEFUL MEASURE FOR INDIVIDUALS WITH RADIATION SKIN REACTIONS IN SCOTTISH CANCER CENTRES
208
MINI MENTAL STATUS EXAMINATION SCORES AS ELIGIBILITY CRITERIA FOR PATIENTS WITH PRIMARY BRAIN TUMORS ENTERING CLINICAL TRIALS
209
COMPREHENSIVE SCREENING AND MANAGEMENT OF DISTRESS
210
THE CHALLENGE OF DEFINING THE COMPLEX ROLE OF THE CLINICAL RESEARCH NURSE.
211
A CROSS-CULTURAL SURVEY (ONCOLOGY NURSING SOCIETY, EUROPEAN ONCOLOGY NURSING SOCIETY, AND MULTINATIONAL ASSOCIATION OF SUPPORTIVE CARE IN CANCER): PERCEPTION OF WORKLOAD, TIME CONSTRAINTS, AND IMPLICATIONS FOR OPTIMIZING ANTIEMETIC TREATMENT
212
PILOT TEST OF A SLEEP INTERVENTION FOR CAREGIVERS OF PEOPLE WITH CANCER
213
NONRESPONSE BIAS: AN ANALYSIS OF DATA FROM A STUDY OF THE ECONOMIC CONSEQUENCES OF CANCER SURVIVORSHIP
214
INFORMATIONAL NEEDS OF KOREAN PATIENTS RECEIVING CHEMOTHERAPY
215
THE LONGITUDINAL EFFECTS OF CANCER TREATMENT ON SEXUALITY IN INDIVIDUALS WITH LUNG CANCER
216
STABILITY AND VALIDITY OF THE PRIORITIES INDEX
217
APPLIED RESEARCH TRAINING SEMINAR: A MENTORING PROGRAM FOR NURSES
218
DEVELOPING A PROFESSIONAL ABSTRACT: A TEAM APPROACH
219
NEW NURSING STRATEGY TO IMPROVE PATIENT UNDERSTANDING OF INFORMED CONSENT FOR PHASE I CLINICAL TRIALS
220
RESPONSE TO ANTIOXIDANT SUPPLEMENTS DURING RADIOTHERAPY
221
THE DEVELOPMENT AND TESTING OF THE ROLE-RELATED MEANING SCALE FOR STAFF IN PEDIATRIC ONCOLOGY
222
PEDIATRIC END-OF-LIFE NURSING EDUCATION
223
LEADING WITH COMPASSION: THE EXPERIENCE OF STUDENTS AND TEACHERS CARING FOR ONCOLOGY PATIENTS
224
AFRICAN AMERICAN WOMEN COPING WITH BREAST CANCER: A QUALITATIVE ANALYSIS
Retention and Recruitment
34
STRATEGIES FOR THE SUCCESSFUL INTEGRATION OF AGENCY NURSES: MEETING THE CHALLENGES OF A NURSING SHORTAGE
169
RETAINING NEW ONCOLOGY NURSES: A CHALLENGE FOR NURSING EDUCATION
170
AN INNOVATIVE STRATEGY FOR REGISTERED NURSE RETENTION: A SELF-CONTAINED UNIT WITH AN AVAILABILITY SYSTEM
171
KEEPING YOUR BEST: STAFF RETENTION.
172
UTILIZING A RECOGNITION DINNER TO ASSESS RETENTION OF ONCOLOGY NURSES
173
A NOVEL CARE DELIVERY MODEL: UTILIZING A FLEXIBLE WORKWEEK TO IMPROVE NURSE RETENTION AND SATISFACTION
174
FINDERS, KEEPERS: IMPROVING RECRUITMENT AND RETENTION: EFFORTS ON AN INPATIENT BLOOD AND MARROW TRANSPLANT UNIT
175
SINK OR SWIM! RESCUE EFFORTS FOCUSED ON IMPROVING TEAMWORK, MORALE, AND CUSTOMER SERVICE THROUGH ADOPTING AN IMAGE OF NURSING SERIES
176
GLUE: A STRATEGY TO IMPROVE NURSE RETENTION
177
ONCOLOGY STAFF NURSES TAKE CONTROL OF THEIR PSYCHOSOCIAL WELLNESS: THE “CIRCLE OF CARE” PROGRAM
Supportive Therapy
30
ADVOCATING FOR FUTURE GENERATIONS: SPERM BANKING
Symptom Management
33
CULTIVATING SYMPTOM MANAGEMENT EXPERTISE ON AN INPATIENT ONCOLOGY UNIT
153
LONG-TERM USE OF VENLAFAXINE FOR HOT FLASHES
154
KNOWLEDGE IS POWER: ASSESSMENT TOOLS THAT EMPOWER PATIENTS TO COMMUNICATE THEIR CHEMOTHERAPY-RELATED SYMPTOMS
155
MYELOSUPPRESSION IN PATIENTS WITH NON-HODGKIN LYMPHOMA TREATED WITH LBRITUMOMAB TIUXETAN (ZEVALIN™)
158
SYMPTOMS EXPERIENCED BY MESOTHELIOMA PATIENTS: USE OF THE LUNG CANCER SYMPTOM SCALE TO ASSESS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
160
DOXIL®-RELATED PALMAR-PLANTAR ERYTHRODYSESTHESIA: NURSING CHALLENGE AND OPPORTUNITY
185
EMPOWERING PATIENTS: ADVANCES IN TECHNOLOGY PROVIDE INNOVATIVE APPROACH TO MANAGING MALIGNANT PLEURAL EFFUSION
191
HYPOVITAMINOSIS D: IMPLICATIONS FOR ONCOLOGY PATIENTS RECEIVING BISPHOSPHONATE THERAPY
|